teotard 350 mg ilgstošās darbības kapsulas
krka, d.d., novo mesto, slovenia - teofilīns - ilgstošās darbības kapsula - 350 mg
uplizna
horizon therapeutics ireland dac - inebilizumab - neuromyelitis optica - imūnsupresanti - uplizna is indicated as monotherapy for the treatment of adult patients with neuromyelitis optica spectrum disorders (nmosd) who are anti-aquaporin 4 immunoglobulin g (aqp4-igg) seropositive (see section 5.
teotard 350 mg ilgstošās darbības kapsulas
krka, d.d., novo mesto, slovenia - teofilīns - ilgstošās darbības kapsula - 350 mg
teotard 200 mg ilgstošās darbības kapsulas
krka, d.d., novo mesto, slovenia - teofilīns - ilgstošās darbības kapsula - 200 mg
dexamethasone medochemie 4 mg/ml šķīdums injekcijām/infūzijām
medochemie ltd., cyprus - deksametazona fosfāts - Šķīdums injekcijām/infūzijām - 4 mg/ml
cimzia
ucb pharma sa - certolizumaba pegols - krona slimība - imūnsupresanti - cimzia, in combination with methotrexate (mtx), is indicated for the treatment of moderate to severe, active rheumatoid arthritis (ra) in adult patients when the response to disease-modifying antirheumatic drugs (dmard) including methotrexate, has been inadequate. cimzia var tikt dota monotherapy gadījumā, ja nepanes metotreksātu vai, ja turpina terapiju ar metotreksātu ir nevietā. cimzia has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function, when given in combination with methotrexate.